Trial
NCT03235986
A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Chiesi Farmaceutici S.p.A.
Collaborators
—
Condition
Neonatal Respiratory Distress Syndrome
Intervention
nCPAP (nasal Continuous Positive Airway Pressure) + Nebulised Curosurf® (Part I)
Why stopped
Change in the benefit-risk balance
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-31